Jayste, who knows how many millions we may have shortly in the bank with upfront payments, exclusivity fees, R and D costs etc. Cash IS coming!
The IP has now been more than validated by a major global resulting in a product launch, this should also see some added share value as well as the income from future sales. Every time one of our technologies (EM, FIM, DERM) is incorporated into a product the value of that technology/IP increases.
As was mentioned earlier, OBJ can now look at some longer term opportunities free of financial insecurities or dependence on consulting partners. Bring on pharmaceuticals! Try and put a limit on its applications...I cant.
- Forums
- ASX - By Stock
- Closing price
Jayste, who knows how many millions we may have shortly in the...
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online